x

ReShape Lifesciences Inc. (Nasdaq:RSLS)

Health Care/Life Sciences • Medical Equipment/Supplies
CIK 1427570
Company

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in Irvine, CA.

Address
18 Technology Drive
Suite 110
Irvine, California 92618
Employees
31
Stock Info
Close
$0.9900
Day Range
0.9500 - 1.0200
52 Week Range
0.8783 - 29.0000
Average volume
995.29K
Short Interest
82.81K (02/14/25)
% of Float Shorted
N/A
Market Cap
$3.27M
Revenue
$8.68M
Net Income
-$11.39M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$16.3960
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Paul F. Hickey
Executive Chairman
Dan W. Gladney
Lead Independent Director
Gary D. Blackford
Independent Director
Lori Courtney McDougal
Independent Director
Arda M. Minocherhomjee
SEC filings
DateFormEvent
20 Dec, 2024 S-1
11 Dec, 2024 8-K
11 Dec, 2024 425
6 Dec, 2024 S-4/A
2 Dec, 2024 8-K
14 Nov, 2024 10-Q
14 Nov, 2024 8-K
17 Oct, 2024 8-K
1 Oct, 2024 S-4
26 Sep, 2024 SC 13G/A
24 Sep, 2024 8-K
28 Aug, 2024 425
28 Aug, 2024 425
14 Aug, 2024 10-Q
14 Aug, 2024 8-K
13 Aug, 2024 4
9 Jul, 2024 8-K
9 Jul, 2024 425
21 Jun, 2024 RW
20 May, 2024 8-K
15 May, 2024 10-Q
9 May, 2024 S-3
10 Apr, 2024 8-K
10 Apr, 2024 8-K
4 Apr, 2024 8-K
1 Apr, 2024 10-K
26 Feb, 2024 8-K
24 Jan, 2024 DEF 14A
18 Jan, 2024 8-K
17 Jan, 2024 SC 13G
16 Jan, 2024 3
5 Jan, 2024 PRE 14A
29 Nov, 2023 8-K
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
8 Nov, 2023 4
13 Oct, 2023 8-K
5 Oct, 2023 8-K
3 Oct, 2023 424B4
29 Sep, 2023 EFFECT
28 Sep, 2023 CORRESP
27 Sep, 2023 S-1/A
22 Sep, 2023 8-K
12 Sep, 2023 S-1/A
30 Aug, 2023 UPLOAD
25 Aug, 2023 S-1
7 Aug, 2023 10-Q
7 Aug, 2023 8-K
19 Jul, 2023 4
6 Jul, 2023 4
23 Jun, 2023 S-8
16 May, 2023 8-K
15 May, 2023 10-Q
26 Apr, 2023 8-K
24 Apr, 2023 424B5
17 Apr, 2023 10-K
13 Apr, 2023 8-K
3 Apr, 2023 NT 10-K
21 Mar, 2023 8-K
17 Mar, 2023 SC 13D
7 Mar, 2023 4
15 Feb, 2023 SC 13D
14 Feb, 2023 SC 13G/A
10 Feb, 2023 8-K
8 Feb, 2023 424B4
3 Feb, 2023 RW WD
3 Feb, 2023 EFFECT
3 Feb, 2023 CORRESP
3 Feb, 2023 S-1/A
3 Feb, 2023 CORRESP
3 Feb, 2023 S-1MEF
2 Feb, 2023 RW
2 Feb, 2023 RW
2 Feb, 2023 S-1/A
1 Feb, 2023 CORRESP
1 Feb, 2023 CORRESP
27 Jan, 2023 8-K
27 Jan, 2023 S-1/A
20 Jan, 2023 UPLOAD
12 Jan, 2023 S-1
28 Dec, 2022 8-K
20 Dec, 2022 8-K
20 Dec, 2022 4
14 Nov, 2022 8-K
14 Nov, 2022 10-Q
14 Nov, 2022 8-K
10 Nov, 2022 4
10 Nov, 2022 DEF 14A
9 Nov, 2022 424B5
31 Oct, 2022 PRE 14A
6 Oct, 2022 4
12 Sep, 2022 4
26 Aug, 2022 3
19 Aug, 2022 10-Q
16 Aug, 2022 NT 10-Q
16 Aug, 2022 8-K
11 Aug, 2022 4
11 Aug, 2022 4
2 Aug, 2022 8-K CEO Change
25 Jul, 2022 8-K
21 Jul, 2022 8-K
6 Jul, 2022 4
6 Jul, 2022 4
23 Jun, 2022 8-K
6 Jun, 2022 4
6 Jun, 2022 4
1 Jun, 2022 4
23 May, 2022 10-Q
23 May, 2022 8-K
13 May, 2022 NT 10-Q
12 May, 2022 4
12 May, 2022 4
14 Apr, 2022 8-K
8 Apr, 2022 4
8 Apr, 2022 10-K
8 Apr, 2022 4
1 Apr, 2022 NT 10-K
28 Mar, 2022 8-K
22 Mar, 2022 8-K/A
17 Mar, 2022 8-K
2 Mar, 2022 4
2 Mar, 2022 4
15 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
2 Feb, 2022 4
2 Feb, 2022 4
28 Jan, 2022 4
28 Jan, 2022 4
9 Dec, 2021 4
9 Dec, 2021 4
18 Nov, 2021 4
16 Nov, 2021 4
16 Nov, 2021 4
12 Nov, 2021 8-K
12 Nov, 2021 10-Q
12 Oct, 2021 4
12 Oct, 2021 4
21 Sep, 2021 424B3
17 Sep, 2021 4
17 Sep, 2021 EFFECT
17 Sep, 2021 EFFECT
17 Sep, 2021 4
17 Sep, 2021 4
17 Sep, 2021 4
17 Sep, 2021 4
17 Sep, 2021 4
15 Sep, 2021 CORRESP
10 Sep, 2021 UPLOAD
3 Sep, 2021 S-3
3 Sep, 2021 S-3
31 Aug, 2021 4
24 Aug, 2021 4
16 Aug, 2021 8-K
16 Aug, 2021 10-Q
19 Jul, 2021 8-K
2 Jul, 2021 8-K
30 Jun, 2021 SC 13G/A
30 Jun, 2021 SC 13D/A
29 Jun, 2021 4
25 Jun, 2021 SC 13D
24 Jun, 2021 3
24 Jun, 2021 3
24 Jun, 2021 3
24 Jun, 2021 3
24 Jun, 2021 3
24 Jun, 2021 3
22 Jun, 2021 4
22 Jun, 2021 3
21 Jun, 2021 SC 13D/A
15 Jun, 2021 8-K
15 Jun, 2021 8-K CEO Change
26 May, 2021 8-K
21 May, 2021 8-K
21 May, 2021 425
18 May, 2021 425
18 May, 2021 425
18 May, 2021 8-K
13 May, 2021 8-K
13 May, 2021 425
12 May, 2021 8-K
12 May, 2021 10-Q
4 May, 2021 425
4 May, 2021 8-K
13 Apr, 2021 EFFECT
13 Apr, 2021 424B3
9 Apr, 2021 S-4/A
9 Apr, 2021 CORRESP
30 Mar, 2021 S-4
15 Mar, 2021 SC 13D/A
12 Mar, 2021 10-K
12 Mar, 2021 8-K
16 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
10 Feb, 2021 8-K
3 Feb, 2021 S-8
22 Jan, 2021 8-K
20 Jan, 2021 425
20 Jan, 2021 425
20 Jan, 2021 8-K
8 Jan, 2021 SC 13G/A
Last update:2025-03-06 13:20:25.485833
ReShape Lifesciences Inc. by TradingView

Sign Up to Subscribe